loading...| Preferred Name |
gadoteridol |
| Synonyms |
Prohance |
| ID |
http://purl.bioontology.org/ontology/MESH/C062402 |
| altLabel |
Prohance SQ 32692 Gd(DO3A) Gd-hydroxypropyl-D03A Gd-HPDO3A gadolinium HP-DO3A SQ 32,692 gadolinium 1,4,7-tris(carboxymethyl)-10-(2'-hydroxypropyl)-1,4,7,10-tetraazacyclododecane Gd-HP-D03A Gd-HP-DO3A GdHPDO3A gadolinium 1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane SQ-32692 |
| cui |
C0084621 C0060930 C0245925 |
| HM |
D009942 D006571 D005682 |
| Inverse of RB |
0199MV609F 0 |
| isa | |
| LT |
TRD |
| Mapped to |
http://purl.bioontology.org/ontology/MESH/D005682 |
| MDA |
19900216 |
| MeSH Frequency |
472 |
| MMR |
20141027 |
| notation |
C062402 |
| PA |
D003287 |
| prefLabel |
gadoteridol |
| RR |
112188-16-6 (gadoteridol) |
| SC |
1 |
| Scope Statement |
nonionic magnetic resonance contrast agent; structure given in first source |
| SRC |
Int J Rad Appl Instrum (B) 1989;16(6):561 |
| TERMUI |
T202749 T211642 T211639 T211643 T702154 T202750 T211641 T202752 T211637 T630679 T202751 T211638 T202748 T211640 |
| TH |
USP (19XX) DE USAN (19XX) NLM (1990) NLM (2007) NLM (2005) INN (19XX) ES |
| tui |
T109 T121 T130 |